Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$194.09 - $276.37 $3,881 - $5,527
-20 Reduced 0.73%
2,710 $539,000
Q1 2022

Apr 18, 2022

BUY
$245.33 - $277.77 $35,082 - $39,721
143 Added 5.53%
2,730 $730,000
Q4 2021

Jan 19, 2022

BUY
$236.63 - $276.44 $116,185 - $135,732
491 Added 23.43%
2,587 $692,000
Q3 2021

Oct 22, 2021

BUY
$248.9 - $280.09 $497 - $560
2 Added 0.1%
2,096 $553,000
Q2 2021

Aug 09, 2021

SELL
$242.95 - $267.0 $9,960 - $10,947
-41 Reduced 1.92%
2,094 $544,000
Q1 2021

May 05, 2021

BUY
$221.01 - $248.82 $19,227 - $21,647
87 Added 4.25%
2,135 $520,000
Q4 2020

Feb 09, 2021

BUY
$202.01 - $245.04 $2,828 - $3,430
14 Added 0.69%
2,048 $501,000
Q3 2020

Oct 23, 2020

BUY
$177.77 - $215.81 $75,018 - $91,071
422 Added 26.18%
2,034 $424,000
Q2 2020

Jul 31, 2020

BUY
$144.67 - $207.03 $233,208 - $333,732
1,612 New
1,612 $290,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Cadence Bank Na Portfolio

Follow Cadence Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.